"For more than 25 years, Texan Eye has been a leader in cataract and refractive surgery, providing sophisticated laser and lens implant surgery for patients who only trust their vision to the best. Other specialty services we offer include oculoplastics, pediatric consultations and full service diagnoses and treatment for glaucoma, retinal and corneal disorders. Texan Eye also offers comprehensive eye exams as well as contact lenses and glasses fittings for our patients."

During the past decade, Texan Eye conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 13 clinical trials were completed, i.e. on average, 144.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 8 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texan Eye" #1 sponsor was "Aerie Pharmaceuticals" with 7 trials, followed by "Allergan" with 3 trials sponsored, "Bausch & Lomb Incorporated" with 3 trials sponsored, "Glaukos Corporation" with 2 trials sponsored and "Kala Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

According to Clinical.Site data, the most researched conditions in "Texan Eye" are "Glaucoma" (5 trials), "Ocular Hypertension" (5 trials), "Open Angle Glaucoma" (5 trials), "Cataract" (2 trials) and "Dry Eye Syndromes" (2 trials). Many other conditions were trialed in "Texan Eye" in a lesser frequency.

Most popular intervention types in "Texan Eye" are "Drug" (21 trials), "Device" (4 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "AR-13324 Ophthalmic Solution 0.01%" (2 trials), "AR-13324 Ophthalmic Solution 0.02%" (2 trials), "Latanoprost 0.005%" (2 trials), "Placebo" (2 trials) and "AR-102 0.003% Ophthalmic Solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Texan Eye" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Texan Eye". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Texan Eye, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Texan Eye, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".